SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...

Implementation of novel genetic diagnostic tests is generally driven by technological advances because they promise shorter turnaround times and/or higher diagnostic yields. Other aspects, including ...

Findings suggest the test can reduce the need for PET imaging in some patients with mild cognitive decline to enable therapeutic focus on non-Alzheimer's disease causes, broadening access to quality ...

Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...

GENT, Belgium & MALVERN, Pa. & TOKYO, January 28, 2026--(BUSINESS WIRE)--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 ...

NCD Will Integrate Firefly’s BNA Technology into its Patient Management Protocols for Enhanced Brain Function Insights and Improved Patient Outcomes TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Firefly ...

HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric ...

TORONTO, ON / ACCESSWIRE / January 19, 2023 / AVAIL SCIENTIFIC (OTC PINK:MOBO) is pleased to announce it is entering into a letter of intent (LOI) to acquire Florida based Relai Neuro LLC which ...

HOT SPRINGS, Ark., March 03, 2026 (GLOBE NEWSWIRE) -- New Way Neurology is now open and serving patients at 100 Ridgeway St., ...

(MENAFN- AETOSWire) (BUSINESS WIRE ) -- H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully ...